Skip to main content
Fig. 8 | BMC Complementary Medicine and Therapies

Fig. 8

From: In-silico and in-vitro assessments of some fabaceae, rhamnaceae, apocynaceae, and anacardiaceae species against Mycobacterium tuberculosis H37Rv and triple-negative breast cancer cells

Fig. 8

Dose–response curve of the cytotoxicity of the medicinal plants S. brachypetala (H1), R. caffra (H2, D2, EA2), S. molle (H3, EA3,), Z. mucronata (H4, C4), S. petersiana (C5, D5), and the reference control drug (Cisplatin) against MDA-MB 231 triple-negative breast cancer cell line. Cells were treated with incubated varying concentrations of the selected crude extract for 48 h, after which an MTT assay was performed. The data points shown represent the mean ± the standard deviation of technical and biological triplicate repeats. The data were analysed using GraphPad Prism 8 software to obtain the IC50 concentrations

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us